Use of nonopioid directives authorized, and immunity for certain acts or failures to act established.
Summary
HF1379 authorizes Minnesota patients, or their health care agents, to execute a “nonopioid directive” stating that the patient must not be administered an opioid or offered an opioid prescription. The bill defines key terms such as “nonopioid directive,” “prescriber,” and “emergency medical services provider,” and it requires health care providers to place a valid directive, and any revocation of it, into the patient’s health record.
The bill also creates a new section in chapter 145C governing how these directives work. A patient with capacity may execute and revoke a directive, and a health care agent may execute or revoke one on the patient’s behalf under specified procedures. Prescribers and health professionals generally must comply, but the bill allows an exception in emergency circumstances when an opioid is medically necessary and it is not practical to access the patient’s record. In that situation, the provider must ensure the patient receives information about substance use disorder services.
Impact
The bill amends Minnesota Statutes chapter 145C and adds a new statutory framework for nonopioid directives in health care decision-making. It requires the Department of Health to create and publish a standardized form, and it imposes recordkeeping duties on providers when a directive or revocation is presented. It also grants immunity from criminal prosecution, civil liability, and professional discipline for covered health professionals, health care facilities, their employees, and emergency medical services providers when they reasonably and in good faith comply with, fail to comply with, or inadvertently administer an opioid under the bill’s conditions.
Sentiment
The available context shows no recorded votes or committee transcript debate, so there is no documented floor or committee sentiment to assess directly. Based on the bill’s structure, it appears designed as a patient-choice and provider-protection measure, balancing opioid avoidance preferences with emergency medical exceptions and liability protections. The caption and amendments suggest the bill was treated as a health policy measure rather than a controversial partisan issue in the available record.
Contention
The main policy tension in the bill is between honoring a patient’s directive to avoid opioids and preserving clinician discretion in emergencies or when opioids are medically necessary. Another potential point of contention is the scope of immunity, since the bill shields providers, facilities, employees, and EMS personnel from liability when acting reasonably and in good faith. The emergency exception, the requirement to provide substance use disorder information after an opioid is administered, and the role of health care agents in executing or revoking directives are the most likely areas for debate.
Commissioner of health required to establish a provider orders for life-sustaining treatment program, rulemaking authorized, data classified, immunity established for certain acts, and money appropriated.